Business & Industry

Aspen reports rise in profits on overseas business

South African generic drug maker Aspen Pharmacare reported a 23 percent increase in first-half profit on Thursday, boosted by robust performance from its overseas business. Africa‘s biggest maker of generics said diluted normalised headline EPS totalled 468.1 cents in the six months to end-December compared with 380 cents a year earlier. Headline EPS, the main profit gauge

IFC extends facility to Nigeria pharmacy chain, HealthPlus

The International Finance Corporation (IFC), a member of the World Bank Group, has announced an agreement with HealthPlus Limited and CasaBella International Limited to provide a $5 million loan facility that will help the two companies expand pharmaceutical and personal care services in Nigeria.


NovaBay signs distribution agreement with the Biopharm Group

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, has signed an exclusive distribution agreement for NovaBay’s NeutroPhase Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt. Under the terms of the agreement, Biopharm will market NeutroPhase




Aspen sells generics drugs unit in Australia to Strides Arcolab

Bangalore, India-based Strides Arcolab today announced it will acquire a generic pharmaceutical business in Australia from South Africa’s Aspen Pharmacare, together with a portfolio of branded and generic products. The business and assets being acquired from Aspen, which will facilitate a re-entry of Strides in the Australian market, will operate under the Arrow Pharmaceuticals brand, selling approximately

Policy & Regulatory Affairs


NAFDAC’s Drug Control Lab Gets International Accreditation

The U.S. Agency for International Development (USAID)’s Director in Nigeria, Michael T. Harvey, today presented the International Organization for Standardization quality certificate to the National Agency for Food and Drug Administration and Control (NAFDAC) Central Drug Control Laboratory in Yaba, Lagos. NAFDAC becomes the third national quality control lab in Africa to achieve ISO 17025 accreditation

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Pharma Projects


Nigeria government in partnership to finance pharmaceutical warehouse in Abuja

The Federal Government of Nigeria, through the Federal Ministry of Health, and in collaboration with the U.S. government through the United States Agency for International Development (USAID) and Global Fund has started construction of three pharmaceutical warehouses in Abuja. . Supervising Minister of Health, Dr Khaliru Alhassan, said the project would be completed within five months at

Plans set for new ARV production plant in Ghana

Oxford International Biomedical Ventures (OIBV), the ‘commercial arm’ of  United Kingdom-based charitable organisation Oxford International Biomedical Centre (OIBC) and the Government of Ghana (GoG) led by the Ministry of Environment, Science and Technology (MEST), are set to jointly establish a plant to manufacture anti-retroviral drugs and drugs for Priority Endemic Diseases in Ghana, OIBC said in a


Hikma appoints Kofi Amegashie to head its sub-Saharan Africa unit

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group has announced the appointment of Kofi Amegashie as head of its newly created sub-Saharan Africa business. Kofi will lead Hikma’s expansion into this region with the aim of replicating Hikma’s brand success in the Middle East and North Africa and establishing a strong foot hold in

Press Releases


China delegation conducts East African visit and seminar

The Chinese Chamber of Commerce for Import & Export of Medicines and Health Products (CCCMHPIE) last month led a delegation to the East African countries of Kenya and Tanzania from Sep. 13 to 19 during which it held in Kenya a seminar titled “Sino-Africa Drug Trade Cooperation – The Seminar on Chinese Medicinal Products”.


What is needed to accelerate access to quality medicines & vaccines in Africa?

GUEST ARTICLE By Paul Dearden, Abbvie;  Dakshina Reddy, Novartis Members of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) African Regulatory Network   In a globalized world, the regulatory landscape is changing every day to address, in tandem, old and new challenges. With regulatory systems increasingly under pressure globally, what will be the most